Literature DB >> 28938172

Artificial intelligence for breast cancer screening: Opportunity or hype?

Nehmat Houssami1, Christoph I Lee2, Diana S M Buist3, Dacheng Tao4.   

Abstract

Interpretation of mammography for breast cancer (BC) screening can confer a mortality benefit through early BC detection, can miss a cancer that is present or fast growing, or can result in false-positives. Efforts to improve screening outcomes have mostly focused on intensifying imaging practices (double instead of single-reading, more frequent screens, or supplemental imaging) that may add substantial resource expenditures and harms associated with population screening. Less attention has been given to making mammography screening practice 'smarter' or more efficient. Artificial intelligence (AI) is capable of advanced learning using large complex datasets and has the potential to perform tasks such as image interpretation. With both highly-specific capabilities, and also possible un-intended (and poorly understood) consequences, this viewpoint considers the promise and current reality of AI in BC detection.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Artificial intelligence; Mammography; Population screening

Mesh:

Year:  2017        PMID: 28938172     DOI: 10.1016/j.breast.2017.09.003

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  15 in total

1.  Artificial Intelligence for Breast Cancer Imaging: The New Frontier?

Authors:  Christoph I Lee; Joann G Elmore
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

2.  A brief introduction to concepts and applications of artificial intelligence in dental imaging.

Authors:  Ruben Pauwels
Journal:  Oral Radiol       Date:  2020-08-16       Impact factor: 1.852

Review 3.  The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I).

Authors:  Tanvi Vaidya; Archi Agrawal; Shivani Mahajan; Meenakshi H Thakur; Abhishek Mahajan
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

4.  Using deep learning to safely exclude lesions with only ultrafast breast MRI to shorten acquisition and reading time.

Authors:  Xueping Jing; Mirjam Wielema; Ludo J Cornelissen; Margo van Gent; Willie M Iwema; Sunyi Zheng; Paul E Sijens; Matthijs Oudkerk; Monique D Dorrius; Peter M A van Ooijen
Journal:  Eur Radiol       Date:  2022-05-26       Impact factor: 5.315

5.  Independent External Validation of Artificial Intelligence Algorithms for Automated Interpretation of Screening Mammography: A Systematic Review.

Authors:  Anna W Anderson; M Luke Marinovich; Nehmat Houssami; Kathryn P Lowry; Joann G Elmore; Diana S M Buist; Solveig Hofvind; Christoph I Lee
Journal:  J Am Coll Radiol       Date:  2022-01-20       Impact factor: 5.532

6.  The impact of artificial intelligence in medicine on the future role of the physician.

Authors:  Abhimanyu S Ahuja
Journal:  PeerJ       Date:  2019-10-04       Impact factor: 2.984

7.  Artificial intelligence in breast cancer screening: primary care provider preferences.

Authors:  Nathaniel Hendrix; Brett Hauber; Christoph I Lee; Aasthaa Bansal; David L Veenstra
Journal:  J Am Med Inform Assoc       Date:  2021-06-12       Impact factor: 4.497

8.  Teaching cross-cultural design thinking for healthcare.

Authors:  Mafalda Falcão Ferreira; Julia N Savoy; Mia K Markey
Journal:  Breast       Date:  2020-01-06       Impact factor: 4.380

9.  The ethical, legal and social implications of using artificial intelligence systems in breast cancer care.

Authors:  Stacy M Carter; Wendy Rogers; Khin Than Win; Helen Frazer; Bernadette Richards; Nehmat Houssami
Journal:  Breast       Date:  2019-10-11       Impact factor: 4.380

10.  Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms.

Authors:  Thomas Schaffter; Diana S M Buist; Christoph I Lee; Yaroslav Nikulin; Dezso Ribli; Yuanfang Guan; William Lotter; Zequn Jie; Hao Du; Sijia Wang; Jiashi Feng; Mengling Feng; Hyo-Eun Kim; Francisco Albiol; Alberto Albiol; Stephen Morrell; Zbigniew Wojna; Mehmet Eren Ahsen; Umar Asif; Antonio Jimeno Yepes; Shivanthan Yohanandan; Simona Rabinovici-Cohen; Darvin Yi; Bruce Hoff; Thomas Yu; Elias Chaibub Neto; Daniel L Rubin; Peter Lindholm; Laurie R Margolies; Russell Bailey McBride; Joseph H Rothstein; Weiva Sieh; Rami Ben-Ari; Stefan Harrer; Andrew Trister; Stephen Friend; Thea Norman; Berkman Sahiner; Fredrik Strand; Justin Guinney; Gustavo Stolovitzky; Lester Mackey; Joyce Cahoon; Li Shen; Jae Ho Sohn; Hari Trivedi; Yiqiu Shen; Ljubomir Buturovic; Jose Costa Pereira; Jaime S Cardoso; Eduardo Castro; Karl Trygve Kalleberg; Obioma Pelka; Imane Nedjar; Krzysztof J Geras; Felix Nensa; Ethan Goan; Sven Koitka; Luis Caballero; David D Cox; Pavitra Krishnaswamy; Gaurav Pandey; Christoph M Friedrich; Dimitri Perrin; Clinton Fookes; Bibo Shi; Gerard Cardoso Negrie; Michael Kawczynski; Kyunghyun Cho; Can Son Khoo; Joseph Y Lo; A Gregory Sorensen; Hwejin Jung
Journal:  JAMA Netw Open       Date:  2020-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.